Trial Profile
Rifaximin plus lactulose versus lactulose alone in treatment of patients with hepatic encephlopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Lactulose (Primary) ; Rifaximin (Primary)
- Indications Hepatic encephalopathy
- Focus Therapeutic Use
- 14 Dec 2015 New trial record